Clinical and biochemical validation of two endophenotypes of schizophrenia defined by levels of polyunsaturated fatty acids in red blood cells.

PubWeight™: 0.85‹?›

🔗 View Article (PMID 22705264)

Published in Prostaglandins Leukot Essent Fatty Acids on June 15, 2012

Authors

H Bentsen1, D K Solberg, H Refsum, T Bøhmer

Author Affiliations

1: Center for Psychopharmacology, Diakonhjemmet Hospital, 0319 Oslo, Norway. havard.bentsen@medisin.uio.no

Articles by these authors

(truncated to the top 100)

Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men. Lancet (2000) 5.61

Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med (1997) 5.35

Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol (1998) 4.48

Vitamin B12 and folate concentrations during pregnancy and insulin resistance in the offspring: the Pune Maternal Nutrition Study. Diabetologia (2007) 2.96

Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine study. Am J Clin Nutr (2000) 2.53

The controversy over homocysteine and cardiovascular risk. Am J Clin Nutr (2000) 2.45

Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study. Am J Clin Nutr (1998) 2.41

Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet (1995) 2.36

Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA (1995) 2.31

Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group. Circulation (1998) 2.31

Biological and clinical implications of the MTHFR C677T polymorphism. Trends Pharmacol Sci (2001) 2.13

Homocysteine and other thiols in plasma and urine: automated determination and sample stability. Clin Chem (1993) 2.07

[Leg cramps in pregnancy--how common are they?]. Tidsskr Nor Laegeforen (1999) 2.05

Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem (1993) 2.01

Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy. J Lab Clin Med (1989) 1.85

Plasma total homocysteine and cardiovascular and noncardiovascular mortality: the Hordaland Homocysteine Study. Am J Clin Nutr (2001) 1.84

Serum total homocysteine and coronary heart disease. Int J Epidemiol (1995) 1.79

Vitamin B12 and folate deficiency in later life. Age Ageing (2004) 1.67

Coffee consumption and plasma total homocysteine: The Hordaland Homocysteine Study. Am J Clin Nutr (1997) 1.58

Cardioprotective effects of the MR contrast agent MnDPDP and its metabolite MnPLED upon reperfusion of the ischemic porcine myocardium. Acta Radiol (2001) 1.55

A common methylenetetrahydrofolate reductase gene mutation and longevity. Atherosclerosis (1998) 1.50

Efficacy and safety of cholestyramine therapy in peripubertal and prepubertal children with familial hypercholesterolemia. J Pediatr (1996) 1.47

Factor V Leiden, pregnancy complications and adverse outcomes: the Hordaland Homocysteine Study. QJM (2006) 1.46

Impact of the ultrarapid CYP2C19*17 allele on serum concentration of escitalopram in psychiatric patients. Clin Pharmacol Ther (2007) 1.43

Low serum calcidiol concentration in older adults with reduced muscular function. J Am Geriatr Soc (1999) 1.43

Vitamin B12 status and rate of brain volume loss in community-dwelling elderly. Neurology (2008) 1.39

Contributions of a transient outward current to repolarization in human atrium. Am J Physiol (1989) 1.36

Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus. Kidney Int (1999) 1.31

Homocysteine and its disulfide derivatives: a suggested consensus terminology. Arterioscler Thromb Vasc Biol (2000) 1.30

The prevalence of undiagnosed protein-calorie undernutrition in a population of hospitalized elderly patients. J Am Geriatr Soc (1991) 1.28

Serum concentrations of risperidone and 9-OH risperidone following intramuscular injection of long-acting risperidone compared with oral risperidone medication. Acta Psychiatr Scand (2006) 1.27

Improved vascular endothelial function after oral B vitamins: An effect mediated through reduced concentrations of free plasma homocysteine. Circulation (2000) 1.23

Total homocysteine and cardiovascular disease. J Intern Med (1999) 1.23

Short-chain fatty acids in the normal human feces. Scand J Gastroenterol (1984) 1.21

Plasma total cysteine as a risk factor for vascular disease: The European Concerted Action Project. Circulation (2001) 1.20

Underestimation of the importance of homocysteine as a risk factor for cardiovascular disease in epidemiological studies. J Cardiovasc Risk (2001) 1.17

Functional modeling of vitamin responsiveness in yeast: a common pyridoxine-responsive cystathionine beta-synthase mutation in homocystinuria. Hum Mol Genet (1997) 1.13

Biological and environmental determinants of plasma homocysteine. Semin Thromb Hemost (2000) 1.13

Signs of impaired cognitive function in adolescents with marginal cobalamin status. Am J Clin Nutr (2000) 1.12

Raised plasma homocysteine as a risk factor for retinal vascular occlusive disease. Br J Ophthalmol (2000) 1.11

Kinetics of thiamin and thiamin phosphate esters in human blood, plasma and urine after 50 mg intravenously or orally. Eur J Clin Pharmacol (1993) 1.11

Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (> or = 40 micromol/liter). The Hordaland Homocysteine Study. J Clin Invest (1996) 1.09

Reduced nutritional status in an elderly population (> 70 y) is probable before disease and possibly contributes to the development of disease. Am J Clin Nutr (1994) 1.05

Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis. Arterioscler Thromb Vasc Biol (1997) 1.02

Determinants of cobalamin status in newborns. Pediatrics (2001) 1.01

Cobalamin deficiency in general practice. Assessment of the diagnostic utility and cost-benefit analysis of methylmalonic acid determination in relation to current diagnostic strategies. Clin Chem (1999) 1.01

Homocysteine levels in patients with rheumatoid arthritis treated with low-dose methotrexate. Clin Pharmacol Ther (1991) 1.00

Methylenetetrahydrofolate reductase 677 C-->T mutation and coronary heart disease risk in UK Indian Asians. Arterioscler Thromb Vasc Biol (2000) 1.00

Metformin increases total serum homocysteine levels in non-diabetic male patients with coronary heart disease. Scand J Clin Lab Invest (1997) 1.00

Plasma vitamin B12 status and cerebral white-matter lesions. J Neurol Neurosurg Psychiatry (2008) 0.99

Concomitant determination of thiamin and its phosphate esters in human blood and serum by high-performance liquid chromatography. J Chromatogr (1991) 0.99

Class III antiarrhythmic action linked with positive inotropy: effects of the d- and l-isomer of sotalol on isolated rat atria at threshold and suprathreshold stimulation. Pharmacol Toxicol (1988) 0.97

Homocysteine and methylmalonic acid levels in pregnant Nepali women. Should cobalamin supplementation be considered? Eur J Clin Nutr (2001) 0.97

Blood and serum thiamin and thiamin phosphate esters concentrations in patients with alcohol dependence syndrome before and after thiamin treatment. Alcohol Clin Exp Res (1992) 0.96

Rate-dependent class III antiarrhythmic action, negative chronotropy, and positive inotropy of a novel Ik blocking drug, UK-68,798: potent in guinea pig but no effect in rat myocardium. J Cardiovasc Pharmacol (1990) 0.96

Radioenzymic determination of homocysteine in plasma and urine. Clin Chem (1985) 0.96

The 677C-->T mutation in the methylenetetrahydrofolate reductase gene: associations with plasma total homocysteine levels and risk of coronary atherosclerotic disease. Atherosclerosis (1997) 0.95

Experimental hypothermia: effects of core cooling and rewarming on hemodynamics, coronary blood flow, and myocardial metabolism in dogs. Anesth Analg (1994) 0.95

The Hordaland Homocysteine Studies. Lipids (2001) 0.95

Serum total homocysteine and coronary heart disease: prospective study in middle aged men. Heart (1999) 0.94

Lifestyle and cardiovascular disease risk factors as determinants of total cysteine in plasma: the Hordaland Homocysteine Study. Am J Clin Nutr (1999) 0.94

Combined analyses and extended follow-up of two randomized controlled homocysteine-lowering B-vitamin trials. J Intern Med (2010) 0.94

Four common mutations of the cystathionine beta-synthase gene detected by multiplex PCR and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin Chem (1999) 0.92

Apolipoprotein E epsilon4 and impaired episodic memory in community-dwelling elderly people: a marked sex difference. The Hordaland Health Study. J Neurol Neurosurg Psychiatry (2006) 0.91

Kinetic basis of hyperhomocysteinemia in patients with chronic renal failure. Kidney Int (1997) 0.91

Recurrent nerve/ansa cervicalis nerve anastomosis: a treatment alternative in unilateral recurrent nerve paralysis. Acta Otolaryngol (1992) 0.91

Serum concentrations of sertraline and N-desmethyl sertraline in relation to CYP2C19 genotype in psychiatric patients. Eur J Clin Pharmacol (2008) 0.90

Variability and determinants of total homocysteine concentrations in plasma in an elderly population. Clin Chem (1998) 0.90

Electrophysiological effects of melperone in the dog heart in situ - a new antiarrhythmic drug. Cardiovasc Res (1981) 0.90

Reduced, oxidized and protein-bound forms of homocysteine and other aminothiols in plasma comprise the redox thiol status--a possible element of the extracellular antioxidant defense system. J Nutr (1996) 0.89

Effect of physiological doses of oral vitamin B12 on plasma homocysteine: a randomized, placebo-controlled, double-blind trial in India. Eur J Clin Nutr (2010) 0.89

Methylmalonic acid and homocysteine in plasma as indicators of functional cobalamin deficiency in infants on macrobiotic diets. Pediatr Res (1994) 0.89

Short-chain fatty acids in intestinal content of germfree mice monocontaminated with Escherichia coli or Clostridium difficile. Scand J Gastroenterol (1985) 0.89

Prevalences of hyperhomocysteinemia, unfavorable cholesterol profile and hypertension in European populations. Eur J Clin Nutr (2005) 0.89

Cardiac electrophysiology, arrhythmogenic mechanisms and roentgen contrast media. Acta Radiol Suppl (1995) 0.88

Short-chain fatty acids in the proximal gastrointestinal tract of healthy subjects. Scand J Gastroenterol (1984) 0.88

Risk of persistent cobalamin deficiency in adolescents fed a macrobiotic diet in early life. Am J Clin Nutr (1999) 0.88

Absorption of short-chain fatty acids from the human colon measured by the 14CO2 breath test. Scand J Gastroenterol (1982) 0.87

Thiamin and thiamin phosphate ester deficiency assessed by high performance liquid chromatography in four clinical cases of Wernicke encephalopathy. Alcohol Clin Exp Res (1993) 0.87

Homocysteine export from cells cultured in the presence of physiological or superfluous levels of methionine: methionine loading of non-transformed, transformed, proliferating, and quiescent cells in culture. J Cell Physiol (1991) 0.87

Influence of beta-adrenergic and cholinergic blockade on the electrophysiological effects of melperone in the dog heart in situ. Cardiovasc Res (1981) 0.87

The association of fasting plasma sulfur-containing compounds with BMI, serum lipids and apolipoproteins. Nutr Metab Cardiovasc Dis (2011) 0.87

Distribution and determinants of serum creatinine in the general population: the Hordaland Health Study. Scand J Clin Lab Invest (2004) 0.87

Plasma total homocysteine levels in hyperthyroid and hypothyroid patients. Metabolism (1998) 0.87

Effect of methotrexate on homocysteine and other sulfur compounds in tissues of rats fed a normal or a defined, choline-deficient diet. Cancer Chemother Pharmacol (1988) 0.86

Homocysteine in frozen plasma samples. A short cut to establish hyperhomocysteinaemia as a risk factor for arteriosclerosis? Scand J Clin Lab Invest (1993) 0.86

Low levels of serum ascorbic acid in elderly patients with hip fracture. Scand J Clin Lab Invest (1998) 0.85

Methotrexate sensitivity in Down's syndrome: a hypothesis. Cancer Chemother Pharmacol (1990) 0.85

Concentrations of the water-soluble vitamins thiamin, ascorbic acid, and folic acid in serum and cerebrospinal fluid of healthy individuals. Am J Clin Nutr (1992) 0.85

Qualitative differences between beta-adrenergic and alpha-adrenergic inotropic effects in rat heart muscle. Acta Pharmacol Toxicol (Copenh) (1978) 0.85

Folate depletion induced by methotrexate affects methionine synthase activity and its susceptibility to inactivation by nitrous oxide. J Pharmacol Exp Ther (1997) 0.85

Cardiac electrophysiologic and hemodynamic effects related to plasma levels of bupivacaine in the dog. Anesth Analg (1985) 0.85

The effect of the C677T and A1298C polymorphisms in the methylenetetrahydrofolate reductase gene on homocysteine levels in elderly men and women from the British regional heart study. Atherosclerosis (2001) 0.85

Reduced concentrations of several vitamins in normal weight patients with late-onset dementia of the Alzheimer type without vascular disease. J Nutr Health Aging (2004) 0.85

Intrauterine growth retardation, perinatal death, and maternal homocysteine levels. N Engl J Med (1992) 0.85

Homocysteine remethylation during nitrous oxide exposure of cells cultured in media containing various concentrations of folates. J Pharmacol Exp Ther (1992) 0.83

Pericardial pressure assessed by right atrial pressure: a basis for calculation of left ventricular transmural pressure. Am Heart J (1984) 0.83

Relation of total homocysteine and lipid levels in children to premature cardiovascular death in male relatives. Pediatr Res (1996) 0.83

Analysis of single-strand conformation polymorphism by capillary electrophoresis with laser-induced fluorescence detection using short-chain polyacrylamide as sieving medium. Anal Biochem (1997) 0.83

Effects of thoracic epidural analgesia on cardiovascular function and plasma concentration of free fatty acids and catecholamines in the dog. Acta Anaesthesiol Scand (1984) 0.83